Keith Regnante - CHIEF FINANCIAL OFFICER at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
KROS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Keith Regnante since 4/23/2024

Holdings reported by Keith Regnante for Keros Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 44K $1.94M $44.01 Feb 18, 2025 Direct

Transactions reported by Keith Regnante for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.